PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2073697
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2073697
Vegetarian Capsules market size was valued at US$ 1,980.7 Million in 2025, expanding at a CAGR of 10.2% from 2026 to 2033.
Vegetarian capsules consist of the natural origin, two-piece, and hard shells that deliver the pharmaceutical medications, neutraceuticals, and nutritional supplements in a variety of liquid and powder fill solutions. Based on the HPMC (hydroxypropyl methylcellulose) and also pullulan origins, the capsules are the most popular alternative to gel caps for those requiring non-animal-based fills. Capsules offer optimum strength and a lower moisture level as well as superior oxygen protection capabilities while being suitable for a wide range of formulations and satisfying the growing trend of vegan, vegetarian, and religion-conformable dosage forms. Thus, the technologies used in the plant-based capsules remain relevant to pharmaceutical and nutraceutical applications.
Vegetarian Capsules Market- Market Dynamics
Increasing consumer awareness of plant-based supplementation driving market demand
There has been an increase in the use of vegetarian capsules due to growing consumer awareness regarding plant-based supplementation, along with rising demand for clean-label and vegan healthcare products. The demand is further supported by increased consumption of natural dietary supplements and a stronger focus on health and wellness. For instance, in 2026, as per the government of the Netherlands, increased consumer awareness about plant-based supplements is contributing to demand in Europe, where the market for food supplements is estimated to be around USD 46,000 million. Such a demand pattern has been driven by a high consumer adoption rate of such supplements, where 9 out of 10 Europeans consume food supplements, and 50% of the world's population is searching for botanicals that can help in boosting their immune system, brain, and gut functions. Therefore, the growing demand for plant-based nutrition and clean-label healthcare products will play a vital role in propelling the demand for vegetarian capsules.
The Global Vegetarian Capsules market is segmented on the basis of Product, Application, Functionality, Distribution Channel, End User, and Region.
In terms of application, vitamins and dietary supplements hold a prominent share in the Vegetarian Capsules market due to the shifting consumer preference toward plant-based supplements, rising health awareness among individuals, and increasing demand for clean-label nutraceutical products. For instance, in 2025, according to NIH.gov, analysis of 29,216 U.S. adults based on NHANES data in 2025 shows that the percentage of dietary supplement use has gone up from 51.8% to 61.4%, which shows that people have been increasingly opting for vitamins and dietary supplements. Thus, the growing use of dietary supplements has resulted in boosting the demand for vegetarian capsules in the field of nutraceuticals.
Vegetarian Capsules Market- Geographical Insights
Asia Pacific holds a significant share of the Vegetarian Capsules market due to the high growth rate in the pharmaceutical manufacturing sector and the increasing demand for vegetarian capsule formulations. For instance, in March 2026, according to the Government of India, the growth of pharmaceutical production will be further facilitated through massive investment under PLI (Production Linked Incentive) schemes, where the cumulative investment till September 2025 reached ₹40,890 crore compared to the committed target of ₹17,275 crore. The scheme has helped achieve a cumulative sales figure of ₹31,549.2 crore, including ₹20,272.4 crore of export sales, contributing towards the manufacturing of 726 important pharmaceutical products. Hence, expanding pharmaceutical manufacturing continues to support demand for vegetarian capsule formulations.
The US Vegetarian Capsule market is expected to expand because of the growing demand for plant-based supplements and medication in order to satisfy the growing consumer demand for plant-based capsules as opposed to the animal-based capsules. For instance, in 2025, according to the U.S. National Library of Medicine (PMC), the increased consumer preference for capsules that do not contain animal origins leads to more adoption of plant-based capsule technology within the U.S. pharmaceutical and nutraceutical industries. It was found that the use of gelatine capsules had been done for over 100 years, whereas HPMC (hydroxypropyl methylcellulose) and starch capsules were preferred by vegetarians, vegans, religious groups, and consumers of clean labels. Hence, increasing preference for plant-based capsules continues to support broader adoption across pharmaceutical and nutraceutical applications.
The Vegetarian Capsule market is moderately competitive, with key players including Capsugel, ACG Worldwide, Qualicaps, Suheung Co., Ltd., and CapsCanada Corporation expanding production volumes by introducing advanced technology for producing capsules from plant-based encapsulating ingredients. The global firms in the market are mainly focusing on the production of HPMC & pullulan capsules due to increasing demand for vegetarian capsules from the pharma and nutraceutical sectors. In May 2025, Capsugel (Lonza Capsugel) and Sinopharm renewed their Suzhou Capsugel joint venture partnership for an additional 20 years to strengthen empty capsule manufacturing and supply in Asia. The partnership strengthens Capsugel's manufacturing footprint in Asia, enhances supply chain resilience, and supports growing demand for vegetarian capsule solutions. This partnership increases the manufacturing capacity of Capsugel in Asia and improves supply chain reliability in the region.
In November 2025, Qualicaps launched QUALIS(R)-Pro, a next-generation UV laser printing and integrated inspection system that enhances capsule and tablet identification, print quality, and manufacturing efficiency. The launch improves production efficiency and quality assurance, reinforcing Qualicaps' technological leadership in advanced capsule manufacturing.
In September 2025, SIRIO Pharma Co., Ltd. entered a strategic partnership with DSM-Firmenich to accelerate the development and commercialization of innovative nutraceutical dosage forms, including plant-based capsule formulations. The partnership expands SIRIO Pharma's nutraceutical portfolio, strengthens its vegetarian capsule capabilities, and accelerates innovation in clean-label supplement delivery systems.